|
|
发表于 2009-6-1 12:29 AM
|
显示全部楼层
|
Just warn you guys that there is a risk that DSCO's drug will never be approved by FDA under the current management. The company's cash is running low and there is a chance that the stock price goes to zero. All it takes is a Class 2 review + more clinical trials. I have owned a large number of shares of DSCO since Apr 2008, and I have already mentally written off this investment. On the plus side, a full FDA approval will ultimately send the stock to $8-10 range. |
|
狗仔卡
发表于 2009-4-21 10:32 AM
这么老的帖子也被顶出来了？
